Accountants reveal entrepreneurial ambitions and interest in sustainability in ACCA's 2025 Global Talent Trends Report
TORONTO, May 13, 2025 (GLOBE NEWSWIRE) -- The third annual Global Talent Trends Survey from ACCA (the Association of Chartered Certified Accountants) alerts employers to changing perspectives among accountancy and finance professionals.
The 2025 report found that many respondents see accountancy as a gateway for entrepreneurial ambitions and skills, with over half of North America respondents (54%) indicating they have career ambitions to be entrepreneurs, including 78% of Gen Z respondents. Additionally, about two-thirds of respondents (66%) are interested in pursuing accountancy careers focused on environmental issues, and 79% agree that reputation on social and human rights issues would be a key factor in deciding whether to work at an organization.
'Our 2025 data continues to show a workplace in transition, but one of the exciting themes emerging this year is how accountancy training can be a brilliant early career pathway for building entrepreneurial skills,' said Jamie Lyon FCCA, Global Head of Skills, Sectors, Technology at ACCA. 'There's no doubt this in part reflects how career ambitions continue to transform at work.'
More than 10,000 individuals from 175 countries participated in the largest talent survey of accountancy and finance professionals, responding to issues ranging from career ambitions, hybrid working and inclusivity practices to upskilling, mental health and employability issues.
'The Talent Trends report offers valuable insights for sector employers on the concerns, aspirations, and preferences of finance professionals across roles and age demographics' said Jillian Couse, Head of ACCA North America. 'For example, with the majority of regional respondents interested in pursuing accountancy careers focused on environmental issues, organizations could consider aligning sustainability efforts with retention goals.'
Topline takeaways from North America (Canada & USA) responses include:
Entrepreneurial ambitions are highest among Gen Z — 78% of the youngest respondents hold aspirations of becoming an entrepreneur or business owner, though more than half of respondents overall (54%) have entrepreneurial ambitions.
Demand for sustainability-related careers is flying high with 66% interested in pursuing accountancy careers focused on environmental issues, including 87% of Gen Z respondents.
Employability confidence is high with 68% wanting to move roles in the next two years and 43% expecting their next career role to be outside their current organization.
Hybrid work is ideal for employees – 71% respondents say that is their preferred working arrangement. Only 12% want to be in the office full time, compared to 35% who report their role is fully office-based (up from 23% in 2024).
The cost of living tops workplace concerns for 41% of respondents, followed by effects of a potential economic downturn (35%). More than half (56%) are dissatisfied with their current wage.
Barriers to social mobility are a growing concern with the number of respondents reporting concern over socioeconomic barriers doubling since our 2024 report (39%, up from 19%).
AI upskilling is falling short — nearly half of respondents are concerned they're not developing the skills required for the future workplace.
Mental health remains a challenge – 46% of respondents report their mental health suffers due to work pressures, and 56% want more support in this area.
Professionals seek global career path – The proportion of respondents from North America (52%) wanting to move internationally has doubled since our 2024 report (28%).
The interactive global report can be found here: https://stories.accaglobal.com/GTT-2025/index.html; the North America regional report can be found here: https://stories.accaglobal.com/GTT-2025/key-regions-headlines/north-america-talent-trends-2025/index.html.
About ACCA
We are ACCA (the Association of Chartered Certified Accountants), a globally recognized accountancy body providing qualifications and advancing standards in accountancy worldwide.
Founded in 1904 to widen access to the accountancy profession, we've long championed inclusion and today proudly support a diverse community of over 252,500 members and 526,000 future members in 180 countries.
Our forward-looking qualifications, continuous learning and insights are respected and valued by employers in every sector. They equip individuals with the business and finance expertise and ethical judgment to create, protect, and report the sustainable value delivered by organisations and economies.
Guided by our purpose and values, our ambition is to lead the accountancy profession for a changed world. Partnering with policymakers, standard setters, the donor community, educators and other accountancy bodies, we're strengthening and building a profession that drives a sustainable future for all.
Find out more at: www.accaglobal.com
ACCA is not affiliated with any Chartered Accountant (CA) organization or Chartered Professional Accountant (CPA) organization.
CONTACT: Media contact: jaime@jaimemwilliams.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
[Latest] Managed Security Services Market Size Will Attain USD 97.12 Billion by 2032 Growing at 14.44% CAGR - Exclusive Report by Zion Market Research (Global Industry Size, Share, Forecast, Trends Analysis Report)
The global managed security services market size was valued at USD 28.84 billion in 2023 and is expected to surpass USD 97.12 billion by 2032, registering a CAGR of 14.44% during the forecast period (2024- 2032). NEW YORK, USA, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled 'Managed Security Services Market By Security (Data Security, Cloud Security, Network Security, and Endpoint Security), By Services (Managed DDoS and Managed Risk & Compliance), By Enterprise (Small & Medium Enterprises and Large Enterprises), By Vertical (BFSI, Defense/Government, Healthcare, IT & Telecom, Manufacturing, and Retail), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2024 - 2032' in its research database. 'According to the latest research study, the global managed security services market size was valued at around USD 28.84 billion in 2023. The market is expected to grow at a CAGR of 14.44% and is anticipated to reach a value of USD 97.12 billion by 2032.'Get a Free Sample PDF of this Research Report for more Insights - (A free sample of this report is available upon request; please get in touch with us for more information.) Managed Security Services Market Overview: Managed security services are network security solutions that are outsourced to a service provider. They are also considered as a systematic approach for effectively handling the security requirements of an organization. These services can be carried out in-house as well as can be outsourced to the service provider that supervises network services & information system security services of other firms. Various functions of managed security services include effective management of firewalls & intrusion detection systems and round-the-clock monitoring of these systems. Apart from this, managed security services also help in monitoring patch management, system updates, security audits, and security assessments along with effectively responding to contingencies. Report Scope: Report Attribute Report Details Market Size in 2023 USD 28.84 Billion Market Forecast in 2032 USD 97.12 Billion Growth Rate CAGR of 14.44% Base Year 2023 Forecast Years 2024- 2032 Key Companies Covered Rapid 7, Fujitsu, AT&T, Verizon, BAE Systems Inc., Cisco Systems, Palo Alto Networks, Check Point Software Technologies, Fortinet Inc., IBM, Wipro, and Others. Segments Covered By Security, By Services, By Enterprise, By Vertical, and By Region Regions Covered North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa Customization Scope Avail customized purchase options to meet your exact research Purchase a Copy of the Report | Quick Delivery Available - Key Insights from Primary Research As per the analysis, the managed security services market share is likely to grow at a CAGR of around 14.44% between 2024 and 2032. The managed security services market size was worth around $28.84 billion in 2023 and is estimated to hit approximately $97.12 billion by 2032. Due to a variety of driving factors, the market is predicted to rise at a significant rate. Based on security, the data security segment is growing at a high rate and is projected to dominate the global market. On the basis of services, the managed DDoS segment is projected to swipe the largest market share. In terms of enterprise, large enterprise segment is likely to grow at a significant rate over the forecast period. Based on vertical, the BFSI segment is predicted to contribute majorly towards the global industry share in the ensuing years. On the basis of region, the Asia-Pacific is expected to dominate the global market during the forecast period. Managed Security Services Market: Growth Drivers An increase in cyber terrorism activities can help the global market register exponential growth over the forecast period The growing complexity of cyber threats is anticipated to propel the expansion of the global managed security services market. Escalating the need for security monitoring and operations associated with the strict execution of security technology will scale up the growth of the global market. Furthermore, managed security solutions include a slew of features enabling firms to effectively manage & protect digital assets from various kinds of cyber terrorism. Reportedly, managed security services include beneficial features such as rapid threat response, threat hunting abilities, 24/7 threat identification, device encryption, remote wipes, and app management for improving security & compliance management. Browse the full 'Managed Security Services Market By Security (Data Security, Cloud Security, Network Security, and Endpoint Security), By Services (Managed DDoS and Managed Risk & Compliance), By Enterprise (Small & Medium Enterprises and Large Enterprises), By Vertical (BFSI, Defense/Government, Healthcare, IT & Telecom, Manufacturing, and Retail), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2024 - 2032' Report at Managed Security Services Market: Segmentation The global managed security services market is divided into security, services, enterprise, vertical, and region. Based on security terms, the managed security services market is divided into data security, cloud security, network security, and endpoint security segments. The data security segment held the largest market share in 2023 and is expected to grow at a significant rate over the forecast period due to the use of data security in IT companies and various other large & small firms to reduce the risk of theft and trespassing, along with enhancing access control to the staff. In terms of services, the global managed security services industry is split into managed DDoS and managed risk & compliance segments. The managed DDoS segment is growing at a high rate and is projected to dominate the global market. On the basis of enterprise, the global managed security services market is segmented into small & medium enterprises and large enterprises segments. The large enterprises segment holds the largest share in 2023, is anticipated to make notable contributions towards the global market proceeds over the assessment timeframe. By vertical, the global managed security services industry is bifurcated into BFSI, defense/government, healthcare, IT & telecom, manufacturing, and retail segments. Moreover, the BFSI segment, which accumulated about 57% of the global industry share in 2023, is expected to make lucrative contributions towards the global industry revenue over the expected timespan. Why does Asia Pacific outperform other regions in the global managed security services market? North America is expected to dominate the global market North America, which accounted for nearly 65% of the global managed security services market earnings in 2023, is anticipated to establish a numero one position in the global market in the years to come. Moreover, the market expansion in North America in the next couple of years can be a result of a humongous demand for outsourcing solutions from a spectrum of tech firms. Furthermore, the huge demand for cloud computing, data security, and network security will augment the regional market surge. The Asia-Pacific managed security services industry is anticipated to register the fastest CAGR in the forecast timespan. The progression of the industry in APAC can be ascribed to the rise in the need for outsourcing managed security solutions from vendors. Furthermore, lack of availability of skilled cyber staff in developing economies of Asia can further accelerate the growth of the industry in the Asia-Pacific. Request For Customization on This Report as Per Your Requirements - Managed Security Services Market: Competitive Landscape The report contains qualitative and quantitative research on the global managed security services market, as well as detailed insights and development strategies employed by the leading competitors. Some of the main players in the global managed security services market include; Rapid 7 Fujitsu AT&T Verizon BAE Systems Inc. Cisco Systems Palo Alto Networks Check Point Software Technologies Fortinet Inc. IBM Wipro. The global managed security services market is segmented as follows: By Security Data Security Cloud Security Network Security Endpoint Security By Services Managed DDoS Managed Risk & Compliance By Enterprise Small & Medium Enterprises Large Enterprises By Vertical BFSI Defense/Government Healthcare IT & Telecom Manufacturing Retail By Region North America The U.S. Canada Europe France The UK Spain Germany Italy Rest of Europe Asia Pacific China Japan India Southeast Asia Rest of Southeast Asia The Middle East & Africa GCC South Africa Rest of the Middle East & Africa Latin America Brazil Argentina Rest of Latin America Request Free Brochure of the Global Managed Security Services Market @ Key Questions Answered in This Report: What are managed security services? Which key factors will influence managed security services market growth over 2024-2032? What will be the value of the managed security services market during 2024-2032? What will be the CAGR value of the managed security services market during 2024-2032? Which region will contribute notably towards the managed security services market value? Which are the major players leveraging the managed security services market growth? What can be expected from the global managed security services market report? Key Offerings: Full in-depth analysis of the parent market Important changes in market dynamics Segmentation details of the market Previous, ongoing, and projected market analysis in terms of volume and value Assessment of niche industry developments Market share analysis Key strategies of major players Emerging segments and regional markets Testimonials to companies in order to fortify their foothold in the market Browse Other Related Research Reports from Zion Market Research AI Price Tracking Tools Market By Data Collection Source (Retailer Websites, Marketplaces, Manufacturer Sites, Direct-to-Consumer [D2C] Brand Sites, Mobile Apps, Physical Store Data), By Component (Solutions, Services), By Technology (Machine Learning, Natural Language Processing [NLP], Computer Vision, Web Scraping & Crawling, Predictive Analytics, and Others), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2025 - 2034 Private 5G Network Market By Component (Services and Hardware), By Frequency (mmWave and Sub-6 GHz), By End-User Vertical (Energy & Utilities, Government & Public Safety, Corporates/Enterprises, Healthcare, Mining, Transportation & Logistics, Automotive, Aerospace, Oil & Gas, and Others), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2025 - 2034 Testing Inspection and Certification Market By Type (Testing, Inspection, and Certification), By Application (Government, Education, Consumer Goods & Retail, Environmental Services, Chemicals, Food, Agriculture, Energy & Power, Infrastructure, Mining, Healthcare, Oil, Gas, & Petroleum, and Others), Market and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2025 - 2034 Consumer Identity and Access Management Market By Component (Solution, Services), By Deployment (On-premises, Cloud-based), By Application (Single Sign-On [SSO], Password less Authentication, and Others), By Industry Vertical (BFSI, Hospitality & Travel, Healthcare, Retail & E-Commerce, Education, Government & Public Sector, and Others), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2025 - 2034 Refurbished IT Asset Disposition Market By Asset Type (Computers/Laptops Disposition, Mobile Devices Disposition, Servers Disposition, and Storage Devices Disposition), By End-User (Banking, Financial Services, and Insurance (BFSI), IT and Telecom, Healthcare Industry, Educational Institutions, Manufacturing, Media and Entertainment, and Others), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2025 - 2034 Sovereign Cloud Market by Component (Solutions and Services), Deployment Mode (Public Cloud, Private Cloud), Cloud Type (IaaS, PaaS, SaaS), End-User (Government & Public Sector, BFSI, Defense, Healthcare, Telecom & IT, Others), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2025 - 2034 About Zion Market Research: Zion Market Research is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Zion Market Research are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our clients'/customers' conviction in our solutions and services has pushed us to always deliver the best. Our advanced research solutions have helped them in making appropriate decision-making and providing guidance for strategies to expand their business. Contact Us: Zion Market Research USA/Canada Toll Free: 1 (855) 465-4651 | Newark: 1 (302) 444-0166 UK: +44 2032 894158 India: +91 7768 006 007 | +91 7768 006 008 Email: sales@ | Web: Follow Us on - LinkedIn | X | Facebook | Pinterest | YouTubeError in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 hours ago
- Yahoo
Aptose Reports Early Data Demonstrating Tuspetinib Improves Standard of Care Treatment Across Diverse Populations of Newly Diagnosed AML in Phase 1/2 TUSCANY Trial
Addition of Tuspetinib (TUS) to Venetoclax (VEN) and Azacitidine (AZA) is being developed as safe and mutation agnostic frontline therapy for AML Addition of TUS to VEN+AZA improves response rates; 100% CR/CRh at 80 mg and 120 mg Addition of TUS to VEN+AZA improves MRD-negativity rates; 78% among responders 100% CR/CRh in FLT3 wildtype AML, representing 70% of AML population 100% CR/CRh and MRD-negativity rates in TP53, RAS and FLT3-ITD mutated AML Broad spectrum activity and excellent safety profile continue at 120 mg dose to date SAN DIEGO and TORONTO, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. ('Aptose' or the 'Company') (OTC: APTOF, TSX: APS), a clinical-stage precision oncology company developing the tuspetinib (TUS)-based triple drug frontline therapy to treat patients with newly diagnosed AML, today provided a data update from the Phase 1/2 TUSCANY trial in newly diagnosed AML. The trial was initiated in December 2024, and the growing body of positive data includes the recently completed third cohort of 120 mg TUS in the TUS+VEN+AZA triplet therapy. Data to date from ten (10) patients across all three cohorts, 40 mg, 80 mg or 120 mg TUS dose in TUS+VEN+AZA, support the use of TUS with standard of care treatment across all AML populations, including those carrying mutations that are the most difficult to treat and those with mutated and unmutated (wildtype) FLT3 genes. The TUS+VEN+AZA triplet is being developed as a safe and well-tolerated mutation agnostic frontline therapy to treat large, mutationally diverse populations of newly diagnosed AML patients who are ineligible to receive induction chemotherapy. At the 120 mg TUS dose level in combination with VEN+AZA, as with the prior reported 40 mg and 80 mg TUS dose cohorts, no significant safety concerns or dose limiting toxicities (DLTs) have been observed in the TUSCANY trial, including no prolonged myelosuppression in Cycle 1 of subjects in remission, no reports of drug-related QTc prolongation or differentiation syndrome (DS), and no treatment-related deaths. Nine out of ten dosed patients remain on study across all dose cohorts and enrollment is being advanced to the 160 mg TUS dose level following the Cohort Safety Review Committee (CSRC) meeting. 'We already have data from three different TUS dose levels in the TUSCANY trial, and the data continue to strengthen at higher doses of TUS and over time. We are building a strong case for TUS+VEN+AZA as a triplet frontline therapy of choice to address a broad AML population, including subgroups with the most adverse of mutations,' said William G. Rice, Ph.D., Chairman, President and Chief Executive Officer of Aptose. Data highlights: Comparison of CR/CRh1 Response rates2-5: VEN+AZA2 TUS+VEN+AZA All subjects 65% 90% (9/10) NPM1-mutant 67% 100% (2/2) FLT3-ITD 61% 100% (2/2) TP53-mutant 52% 100% (2/2) Comparison of MRD-negativity6 rates among All Subjects and among CR/CRh Responders3: VEN+AZA2,3 TUS+VEN+AZA Among All Subjects 23.4% 70% (7/10) Among CR/CRh Responders 40.9% 78% (7/9) Comparison of MRD-negativity rates among more difficult-to-treat Patient Subpopulations defined as Lower Benefit (TP53-mutated) and Intermediate Benefit (FLT3-ITD or RAS-mutated) relative to VEN+AZA5: VEN+AZA3,5 TUS+VEN+AZA Intermediate Benefit 27.9% 100% (3/3) Lower Benefit 14.5% 100% (2/2) TUS+VEN+AZA - CR/CRh and MRD-negativity rates among Subjects with Adverse Mutations: TP53, FLT3-ITD, RAS mutations: Achieved CR/CRh and MRD-negativity 100% (5/5) 'As illustrated in the data highlights, the addition of TUS to VEN+AZA appears to boost response rates and MRD-negativity while maintaining favorable safety and tolerability,' said Rafael Bejar, M.D., Ph.D., Chief Medical Officer of Aptose, 'and the 100% CR/CRh and 100% MRD-negativity rates among the five biallelic TP53-mutant, FLT3-ITD, and RAS-mutant AML cases are exciting to see, as this can correlate with longer overall survival. We have observed a trend towards achieving CRs more quickly at the higher dose levels, so we are keen to see the activity as we advance into the 160 mg TUS dose cohort.' Key messages: Addition of TUS to VEN+AZA demonstrates excellent CR/CRh rates 100% CR/CRh among all subjects treated at 80 mg and 120 mg TUS dose levels Appear to be achieving CR earlier with 120 mg TUS than with 40 mg or 80 mg Addition of TUS to VEN+AZA demonstrates excellent MRD-negativity rates MRD-negativity in 7 of 9 (78%) already achieved in patients who responded to therapy Expect patient survival to be extended with continued long-term treatment Excellent safety and well tolerated with no dose-limiting toxicities (No DLT) at completed dose levels Broad-spectrum activity including patients with adverse TP53, RAS and FLT3-ITD mutations No loss of MRD-negativity observed to date, including in one patient with over 7 months of follow up MRD-negativity and remissions continue to mature over time on therapy No relapses reported to date and no treatment related deaths The only non-responder was a patient at the initial TUS dose level (40 mg) that did not achieve TUS exposures previously associated with response Additional data are included in the new Aptose corporate presentation here. TUSCANY: TUS+VEN+AZA Triplet Phase 1/2 Study The tuspetinib-based TUS+VEN+AZA triplet therapy is being advanced in the TUSCANY Phase 1/2 trial with the goal of creating an improved frontline therapy for newly diagnosed AML patients that is active across diverse AML populations, durable, and well tolerated. The TUSCANY triplet Phase 1/2 study, being conducted at 10 leading U.S. clinical sites by elite clinical investigators, is designed to test various doses and schedules of TUS in combination with standard dosing of AZA and VEN for patients with AML who are ineligible to receive induction chemotherapy. A convenient, once daily oral agent, TUS is being administered in 28-day cycles. Multiple U.S. sites are enrolling in the TUSCANY trial with anticipated enrollment of 18-24 patients by late 2025. Data will be released as it becomes available. More information on the TUSCANY Phase 1/2 study can be found on (here). About Aptose Aptose Biosciences is a clinical-stage biotechnology company committed to developing precision medicines addressing unmet medical needs in oncology, with an initial focus on hematology. The Company's lead clinical-stage, oral kinase inhibitor tuspetinib (TUS) has demonstrated activity as a monotherapy and in combination therapy in patients with relapsed or refractory acute myeloid leukemia (AML) and is being developed as a frontline triplet therapy in newly diagnosed AML. For more information, please visit Forward Looking Statements This press release may contain forward-looking statements within the meaning of Canadian and U.S. securities laws, including, but not limited to, statements relating to the therapeutic potential and safety profile of tuspetinib (including the triplet therapy) and its clinical development, the anticipated enrollment rate in the TUSCANY trial and the timing thereof, as well as statements relating to the Company's plans, objectives, expectations and intentions and other statements including words such as 'continue', 'expect', 'intend', 'will', 'should', 'would', 'may', and other similar expressions. Such statements reflect our current views with respect to future events and are subject to risks and uncertainties and are necessarily based upon a number of estimates and assumptions that, while considered reasonable by us are inherently subject to significant business, economic, competitive, political and social uncertainties and contingencies. Many factors could cause our actual results, performance or achievements to be materially different from any future results, performance or achievements described in this press release. Such factors could include, among others: our ability to obtain the capital required for research and operations and to continue as a going concern; the inherent risks in early stage drug development including demonstrating efficacy; development time/cost and the regulatory approval process; the progress of our clinical trials; our ability to find and enter into agreements with potential partners; our ability to attract and retain key personnel; changing market conditions; inability of new manufacturers to produce acceptable batches of GMP in sufficient quantities; unexpected manufacturing defects; and other risks detailed from time-to-time in our ongoing quarterly filings, annual information forms, annual reports and annual filings with Canadian securities regulators and the United States Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should the assumptions set out in the section entitled 'Risk Factors' in our filings with Canadian securities regulators and the United States Securities and Exchange Commission underlying those forward-looking statements prove incorrect, actual results may vary materially from those described herein. These forward-looking statements are made as of the date of this press release and we do not intend, and do not assume any obligation, to update these forward-looking statements, except as required by law. We cannot assure you that such statements will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. Investors are cautioned that forward-looking statements are not guarantees of future performance and accordingly investors are cautioned not to put undue reliance on forward-looking statements due to the inherent uncertainty therein. For further information, please contact: Aptose Biosciences PietropaoloCorporate Communications & Investor Relations201-923-2049spietropaolo@ 1 Complete Response / Complete Response with Partial Hematological Recovery2 DiNardo et al. New England Journal of Medicine, August 2020; Volume 383(7):617-629.3 Pratz et al. Journal of Clinical Oncology, December 2021; Volume 40 (8):855-865.4 Othman et. al. Blood Neoplasia; September 2024; Volume 1 (3):1-11.5 Döhner et. al. Blood. 2024 November 21;144(21):2211-2222.6 MRD-negative indicates that the amount of Measurable Residual Disease, as assessed by central flow cytometry, is such that the proportion of leukemic cells in a bone marrow sample falls below <0.1%Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 hours ago
- Yahoo
The Apache Software Foundation Announces Apache Ozone 2.0.0
First object store to support operational databases, now with major usability and compatibility enhancements Wilmington, DE, Aug. 19, 2025 (GLOBE NEWSWIRE) -- The Apache Software Foundation (ASF), the global home of open source software the world relies on, today announced Apache Ozone 2.0.0, a major milestone for the cloud-native distributed object store built for big data, analytics, and AI workloads. "Apache Ozone 2.0.0 represents years of community collaboration and production lessons from large-scale deployments,' said Sammi Chen, Apache Ozone PMC Chair and Principal Engineer at Cloudera. 'We're seeing growing adoption of Ozone in production, and this release brings the stability, performance, and ecosystem integration users have asked for." Ozone 2.0.0 responds to growing demand from organizations building AI and analytics platforms that require scalable, fault-tolerant, and cost-efficient storage—without giving up on performance or operational ease. Key Highlights of Apache Ozone 2.0.0: Operational Database Support: Apache Ozone is the first object store to support Apache HBase, enabling low-latency read/write workloads alongside traditional object storage. Atomic Key Operations: Support for atomic key overwrite and key replacement improves consistency for applications running concurrently. Modernized Recon UI: The Ozone Recon monitoring interface has been redesigned for clarity, with better metrics and navigation to support administrators. Expanded Platform Support: Now compatible with JDK 17 and JDK 21, and builds natively on ARM64, enabling broader deployment options. Improved Snapshots: Snapshot operations are more robust and efficient, particularly in large-scale environments with frequent replication or churn. Day-2 Operations: SCM decommissioning is now supported, making it easier to safely remove or rotate hardware as part of lifecycle management. With version 2.0.0, Apache Ozone continues its evolution from an object store for Apache Hadoop to a modern, cloud-native storage platform designed for AI, data lakehouses, and hybrid cloud use cases. For more information on Apache Ozone 2.0.0 and to get started, visit Additional Resources: Download: Documentation: Blog: GitHub: Follow on X/Twitter: @ApacheOzone About The Apache Software Foundation (ASF)The Apache Software Foundation (ASF) is the global home for open source software, powering some of the world's most ubiquitous software projects including Apache Airflow, Apache Camel, Apache Cassandra, Apache Groovy, Apache HTTP Server, and Apache Kafka. Established in 1999, the ASF is at the forefront of open source innovation, setting industry standards to advance software for the public good. Learn more at ASF's annual Community Over Code event is where open source technologists convene to share best practices and use cases, forge critical relationships, and learn about advancements in their field. © The Apache Software Foundation. 'Apache' is a registered trademark or trademark of the Apache Software Foundation in the United States and/or other countries. All other brands and trademarks are the property of their respective Brian Proffitt press@ Vice President, Marketing & Publicity The Apache Software FoundationError in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
